Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Guillaume Beltramo, Jonathan Cottenet, Anne-Sophie Mariet, Marjolaine Georges, Lionel Piroth, Pascale Tubert-Bitter, Philippe Bonniaud, Catherine Quantin
European Respiratory Journal 2021; DOI: 10.1183/13993003.04474-2020
Guillaume Beltramo
1Reference Constitutive Center for Rare Lung Diseases, Department of Pulmonary Medicine and Intensive Care Unit, University Hospital, Dijon, France
2INSERM LNC- UMR 1231, Dijon, France
3University of Bourgogne-Franche-Comté, Dijon, France
8These two authors contributed equally to this work Lionel Piroth, Philippe Bonniaud, Marjolaine Georges and Catherine Quantin are full professors.
Jonathan Cottenet
4Biostatistics and Bioinformatics (DIM), Dijon University Hospital, Dijon, France; Bourgogne Franche-Comté University, Dijon, France
8These two authors contributed equally to this work Lionel Piroth, Philippe Bonniaud, Marjolaine Georges and Catherine Quantin are full professors.
Anne-Sophie Mariet
4Biostatistics and Bioinformatics (DIM), Dijon University Hospital, Dijon, France; Bourgogne Franche-Comté University, Dijon, France
5INSERM, CIC 1432, Dijon, France; Dijon University Hospital, Clinical Investigation Center, clinical epidemiology/ clinical trials unit, Dijon, France
Marjolaine Georges
1Reference Constitutive Center for Rare Lung Diseases, Department of Pulmonary Medicine and Intensive Care Unit, University Hospital, Dijon, France
3University of Bourgogne-Franche-Comté, Dijon, France
Lionel Piroth
3University of Bourgogne-Franche-Comté, Dijon, France
5INSERM, CIC 1432, Dijon, France; Dijon University Hospital, Clinical Investigation Center, clinical epidemiology/ clinical trials unit, Dijon, France
6Infectious Diseases Department, Dijon University Hospital, Dijon, France
Pascale Tubert-Bitter
7Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, France
Philippe Bonniaud
1Reference Constitutive Center for Rare Lung Diseases, Department of Pulmonary Medicine and Intensive Care Unit, University Hospital, Dijon, France
2INSERM LNC- UMR 1231, Dijon, France
3University of Bourgogne-Franche-Comté, Dijon, France
8These two authors contributed equally to this work Lionel Piroth, Philippe Bonniaud, Marjolaine Georges and Catherine Quantin are full professors.
Catherine Quantin
4Biostatistics and Bioinformatics (DIM), Dijon University Hospital, Dijon, France; Bourgogne Franche-Comté University, Dijon, France
5INSERM, CIC 1432, Dijon, France; Dijon University Hospital, Clinical Investigation Center, clinical epidemiology/ clinical trials unit, Dijon, France
7Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, High-Dimensional Biostatistics for Drug Safety and Genomics, CESP, Villejuif, France
8These two authors contributed equally to this work Lionel Piroth, Philippe Bonniaud, Marjolaine Georges and Catherine Quantin are full professors.
Vol 63 Issue 4
Table of Contents
Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Guillaume Beltramo, Jonathan Cottenet, Anne-Sophie Mariet, Marjolaine Georges, Lionel Piroth, Pascale Tubert-Bitter, Philippe Bonniaud, Catherine Quantin
European Respiratory Journal Jan 2021, 2004474; DOI: 10.1183/13993003.04474-2020
Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study
Guillaume Beltramo, Jonathan Cottenet, Anne-Sophie Mariet, Marjolaine Georges, Lionel Piroth, Pascale Tubert-Bitter, Philippe Bonniaud, Catherine Quantin
European Respiratory Journal Jan 2021, 2004474; DOI: 10.1183/13993003.04474-2020